Length of Stay Comparison between Rivaroxaban and Warfarin in the Treatment of Pulmonary Embolism: Results from a Real-World Observational Cohort Study

Background. Trials have shown that novel oral anticoagulants may decrease length of stay versus warfarin. A comparison of length of stay in the treatment of pulmonary embolism (PE) has not been performed outside post hoc analysis of a large clinical trial. Objective. To evaluate if rivaroxaban decre...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberts, Kirsten M., Knight, Tamara B., Padilla-Tolentino, Eimeira, Murthy, Manasa, Peterson, Evan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735940/
https://www.ncbi.nlm.nih.gov/pubmed/26881071
http://dx.doi.org/10.1155/2015/414523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735940/
https://www.ncbi.nlm.nih.gov/pubmed/26881071
http://dx.doi.org/10.1155/2015/414523

Ejemplares similares